• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Reportlinker Adds Human Papillomavirus (HPV) Therapeutics - Pipeline Assessment and Market Forecasts to 2017


News provided by

Reportlinker

Jun 01, 2011, 07:37 ET

Share this article

Share this article


NEW YORK, June 1, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Human Papillomavirus (HPV) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

http://www.reportlinker.com/p0546795/Human-Papillomavirus-HPV-Therapeutics---Pipeline-Assessment-and-Market-Forecasts-to-2017.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Human Papillomavirus (HPV) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, "Human Papillomavirus (HPV) Therapeutics - Pipeline Assessment and Market Forecasts to 2017". The report is an essential source of information and analysis on the global Human Papillomavirus (HPV) Therapeutics market. The report identifies the key trends shaping and driving the global Human Papillomavirus (HPV) Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Human Papillomavirus (HPV) Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Human Papillomavirus (HPV) Therapeutics market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Human Papillomavirus (HPV) Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.

- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes.

- Analysis of the current and future competition in the seven key countries Human Papillomavirus (HPV) Therapeutics market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Human Papillomavirus (HPV) Therapeutics therapeutics market.

- Analysis of key recent licensing and partnership agreements in Human Papillomavirus (HPV) Therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.

- Develop business strategies by understanding the trends shaping and driving the global Human Papillomavirus (HPV) Therapeutics market.

- Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Human Papillomavirus (HPV) Therapeutics market in future.

- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

- What's the next big thing in the global Human Papillomavirus (HPV) Therapeutics market landscape? – Identify, understand and capitalize.

1 Table of contents

1 Table of contents 3

1.1 List of Tables 5

1.2 List of Figures 6

2 HPV Therapeutics - Introduction 7

2.1 Disease Overview 7

2.1.1 Genital warts 7

2.1.2 Cervical cancer 8

2.2 Epidemiology 8

2.3 Etiology and Pathophysiology 9

2.4 Signs and Symptoms 10

2.5 Diagnosis 10

2.5.1 Pap smear 10

2.5.2 Colposcopy 10

2.5.3 Biopsy 10

2.5.4 Human papillomavirus test 11

2.6 Treatment and Management Options 11

2.6.1 Genital Warts treatments 11

2.6.2 Cervical cancer treatments 12

2.7 GlobalData Pipeline Report Guidance 13

3 HPV Therapeutics - Market Characterization 14

3.1 HPV Therapeutics Market Size (2005-2010) – Global 14

3.2 HPV Therapeutics Market Forecast (2010-2017) – Global 15

3.3 HPV Therapeutics Market Size (2005–2010) – The US 16

3.4 HPV Therapeutics Market Forecast (2010-2017) – The US 17

3.5 HPV Therapeutics Market Size (2005–2010) – France 18

3.6 HPV Therapeutics Market Forecast (2010–2017) – France 19

3.7 HPV Therapeutics Market Size (2005–2010) – Germany 20

3.8 HPV Therapeutics Market Forecast (2010–2017) – Germany 21

3.9 HPV Therapeutics Market Size (2005–2010) – Italy 22

3.10 HPV Therapeutics Market Forecast (2010-2017) – Italy 23

3.11 HPV Therapeutics Market Size (2005–2010) – Spain 24

3.12 HPV Therapeutics Market Forecast (2010–2017) – Spain 25

3.13 HPV Therapeutics Market Size (2005–2010) – The UK 26

3.14 HPV Therapeutics Market Forecast (2010–2017) – The UK 27

3.15 HPV Therapeutics Market Size (2005–2010) – Japan 28

3.16 HPV Therapeutics Market Forecast (2010-2017) – Japan 29

3.17 Drivers and Barriers for the HPV Therapeutics Market 30

3.17.1 Barriers for the HPV Therapeutics Market 30

3.18 Opportunity and Unmet Need Analysis 31

3.19 Key Takeaway 32

4 HPV Therapeutics - Competitive Assessment 33

4.1 Overview 33

4.2 Strategic Competitor Assessment 33

4.3 Product Profiles for the Major Marketed Products in the HPV Therapeutics Market 35

4.3.1 Gardasil (HPV quadrivalent (type 6, 11, 16 and 18) vaccine recombinant) 35

4.3.2 Cervarix (human papillomavirus bivalent (type 16, 18) vaccine, recombinant) 36

4.3.3 Condylox (podofilox) 38

4.3.4 Aldara (imiquimod, 5%) 38

4.3.5 Veregen (sinecatechin) 40

4.3.6 Alferon N (interferon alfa-n3) 41

4.4 Newly Approved Drug 42

4.4.1 Zyclara (imiquimod, 3.75%) 42

5 HPV Therapeutics - Pipeline Assessment 44

5.1 Overview 44

5.2 Strategic Pipeline Assessment 44

5.3 HPV Therapeutics Pipeline – Pipeline by Phases of Development 44

5.3.1 HPV Therapeutics – Phase III Pipeline 45

5.3.2 HPV Therapeutics – Phase II Pipeline 45

5.3.3 HPV Therapeutics – Phase I Pipeline 45

5.3.4 HPV Market – Discovery and Pre-Clinical Pipeline 46

5.3.5 Technology Trends Analytic Framework 47

5.4 HPV Therapeutics Market – Clinical Pipeline by Mechanism of Action 48

5.5 HPV Therapeutics – Promising Drugs Under Clinical Development 49

5.6 Molecule Profile for Promising Drugs Under Clinical Development 49

5.6.1 V503 49

5.6.2 LMV-601 50

5.6.3 R3484 50

5.7 Key Takeaway 51

6 HPV Therapeutics - Clinical Trials Mapping 52

6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 52

6.2 Clinical Trials by Phase 53

6.3 Clinical Trials by Trial Status 54

6.4 Prominent Sponsors 55

6.5 Top Companies Participating in HPV Therapeutics Clinical Trials 56

7 Strategic Assessment 57

7.1 Key Events Impacting the Future Market 57

7.2 HPV Therapeutics - Implications for Future Market Competition 58

8 HPV Therapeutics - Future Players 60

8.1 Introduction 60

8.2 Company Profiles 60

8.2.1 Merck & Co 60

8.2.2 Glaskosmithkline plc 65

8.2.3 F.Hoffmann-La Roche Ltd. 70

8.2.4 Inovio Pharmaceuticals,Inc 74

8.2.5 Lumavita AG 76

9 HPV Therapeutics - Licensing and Partnership Deals 77

10 HPV Therapeutics - Appendix 80

10.1 Market Definitions 80

10.2 Abbreviations 80

10.3 Research Methodology Methodology 81

10.3.1 Coverage 81

10.3.2 Secondary Research 82

10.3.3 Forecasting 82

10.3.4 Primary Research 85

10.3.5 Expert Panel Validation 85

10.4 Contact Us 85

10.5 Disclaimer 85

10.6 Bibliography 86

1.1 List of Tables

Table 1: Cervical Cancer Treatment by Stage of the Disease, 2010 12

Table 2: HPV Therapeutics Market, Global, Revenue ($m) 2005–2010 14

Table 3: HPV Therapeutics Market, Global, Forecast ($m), 2010–2017 15

Table 4: HPV Therapeutics Market, The US, Revenue ($m), 2005–2010 16

Table 5: HPV Therapeutics Market, The US, Forecasts ($m), 2010–2017 17

Table 6: HPV Therapeutics Market, France, Revenue ($m), 2005–2010 18

Table 7: HPV Therapeutics Market, France, Forecasts ($m), 2010–2017 19

Table 8: HPV Therapeutics Market, Germany, Revenue ($m), 2005–2010 20

Table 9: HPV Therapeutics Market, Germany, Forecasts ($m), 2010–2017 21

Table 10: HPV Therapeutics Market, Italy, Revenue ($m), 2005–2010 22

Table 11: HPV Therapeutics Market, Italy, Forecasts ($m), 2010–2017 23

Table 12: HPV Therapeutics Market, Spain, Revenue ($m), 2005–2010 24

Table 13: HPV Therapeutics Market, Spain, Forecasts ($m), 2010–2017 25

Table 14: HPV Therapeutics Market, The UK, Revenue ($m), 2005–2010 26

Table 15: HPV Therapeutics Market, The UK, Forecasts ($m) 2010–2017 27

Table 16: HPV Therapeutics Market, Japan, Revenue ($m), 2005–2010 28

Table 17: HPV Therapeutics Market, Japan, Forecasts ($m), 2010–2017 29

Table 18: Zyclara, Clinical Trial Details, Complete Clearance of External Genital Warts Within 16 Weeks of Treatment (%) 43

Table 19: Zyclara, Clinical Trial Details, Complete Clearance of External Genital Warts Within 16 Weeks of Treatment by Gender (%), Combined Study 43

Table 20: HPV Therapeutics Market, Phase III Clinical Pipeline, 2010 45

Table 21: HPV Therapeutics Market, Phase II Clinical Pipeline, 2010 45

Table 22: HPV Therapeutics Market, Phase I Clinical Pipeline, 2010 45

Table 23: HPV Therapeutics Market, Discovery and Pre-Clinical Pipeline, 2010 46

Table 24: HPV Therapeutics Market, Most Promising Drugs Under Clinical Development, 2010 49

Table 25: HPV Therapeutics Market, Number of Clinical Trials by Country, 2010 52

Table 26: HPV Therapeutics Market, Number of Clinical Trials by Phase, 2010 53

Table 27: HPV Therapeutics Market, Number of Clinical Trials by Status, 2010 54

Table 28: HPV Therapeutics Market, Number of Prominent Sponsors, 2010 55

Table 29: HPV Therapeutics Market, Top Companies Participating in Therapeutics Clinical Trials, 2010 56

Table 30: Merck &Co Infectious Diseases, Pipeline, 2010 62

Table 31: Merck &Co, Inc – Deals 63

Table 32: GlaxoSmithKline Plc. – Infectious Diseases, Pipeline, 2010 66

Table 33: GlaxoSmithKline Plc. Deals, Alliances and Partnerships , 2010-2011 67

Table 34: F. Hoffmann-La Roche Ltd ,Infectious Disease Pipeline, 2010 71

Table 35: F. Hoffmann-La Roche Ltd Deals, Alliances and Partnerships , 2010-2011 72

Table 36: Inovio Pharmaceuticals –Infectious Disease, Pipeline, 2010 75

Table 37: Inovio Pharmaceuticals, Inc. – Deals 75

Table 38: Lumavita Infectious Disease Pipeline 76

Table 39: Lmavita AG-Deals 76

Table 40: HPV Therapeutics Market, Global, Deals, 2010 77

1.2 List of Figures

Figure 1: Pathophysiology of HPV 9

Figure 2: HPV Therapeutics Market, Global, Revenue ($m), 2005–2010 14

Figure 3: HPV Therapeutics Market, Global, Forecasts ($m), 2010–2017 15

Figure 4: HPV Therapeutics Market, The US, Revenue ($m), 2005–2010 16

Figure 5: HPV Therapeutics Market, The US, Forecasts ($m), 2010–2017 17

Figure 6: HPV Therapeutics Market, France, Revenue ($m), 2005–2010 18

Figure 7: HPV Therapeutics Market, France, Forecasts ($m), 2010–2017 19

Figure 8: HPV Therapeutics Market, Germany, Revenue ($m), 2005–2010 20

Figure 9: HPV Therapeutics Market, Germany, Forecast ($m), 2010–2017 21

Figure 10: HPV Therapeutics Market, Italy, Revenue ($m), 2005–2010 22

Figure 11: HPV Therapeutics Market, Italy, Forecast ($m), 2010–2017 23

Figure 12: HPV Therapeutics Market, Spain, Revenue ($m), 2005–2010 24

Figure 13: HPV Therapeutics Market, Spain, Forecast ($m), 2010–2017 25

Figure 14: HPV Therapeutics Market, The UK, Revenue ($m), 2005–2010 26

Figure 15: HPV Therapeutics Market, The UK, Forecasts ($m), 2010–2017 27

Figure 16: HPV Therapeutics Market, Japan, Revenue ($m), 2005–2010 28

Figure 17: HPV Therapeutics Market, Japan, Forecasts 2010–2017 29

Figure 18: Opportunity and Unmet Need in the HPV Prophylactic Market, 2010 31

Figure 19: Opportunity and Unmet Need in the HPV Therapeutic Market, 2010 32

Figure 20: HPV Prophylactics Market, Strategic Competitor Assessment, 2010 33

Figure 21: HPV Therapeutics Market, Strategic Competitor Assessment, 2010 34

Figure 22: Aldara Cream, Clinical Trial Details 39

Figure 23: HPV Therapeutics Market, Pipeline by Phase of Development, 2010 44

Figure 24: HPV Therapeutics Market, Technology Trends Analytics Framework, 2010 47

Figure 25: HPV Therapeutics Market, Technology Trends Analytics Framework, Description, 2010 47

Figure 26: HPV Therapeutics Market, Pipeline by Mechanism of Action (%), 2010 48

Figure 27: HPV Therapeutics Market, Number of Clinical Trials by Country, 2010 52

Figure 28: HPV Therapeutics Market, Clinical Trials by Phase (%), 2010 53

Figure 29: HPV Therapeutics Market, Clinical Trials by Status (%), 2010 54

Figure 30: HPV Therapeutics Market, Prominent Sponsors (%), 2010 55

Figure 31: HPV Therapeutics Market, Drivers and Restraints 2010 57

Figure 32: HPV Prophylactics Market, Implications for Future Market Competition, 2010 58

Figure 33: HPV Therapeutics Market, Implications for Future Market Competition, 2010 59

Figure 34: HPV Therapeutics Market, Pipeline by Company, 2010 60

Figure 35: GlobalData Market Forecasting Model 84

Companies Mentioned

Merck & Co

Glaskosmithkline plc

F.Hoffmann-La Roche Ltd.

Inovio Pharmaceuticals,Inc

Lumavita AG

To order this report:

Drug Discovery and Development Industry: Human Papillomavirus (HPV) Therapeutics - Pipeline Assessment and Market Forecasts to 2017

Drug Discovery and Development Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.